Efficacy and safety of a bortezomib and reduced-intensity cytarabine-based protocol, TMC ALLR1, for relapsed childhood ALL in India

Clicks: 241
ID: 31142
2019
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
roy2019efficacybritish Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Roy, P.
Journal British journal of haematology
Year 2019
DOI
10.1111/bjh.16005
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.